# NOGA Angiogenesis Revascularization Therapy: Evaluation by RadioNuclide Imaging - The Northern Trial

> **NCT00143585** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 120 (—)

## Conditions studied

- Myocardial Ischemia

## Interventions

- **PROCEDURE:** intramyocardial delivery of either VEGF165 or placebo

## Key facts

- **NCT ID:** NCT00143585
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 120 (—)
- **Last updated:** 2008-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143585, "NOGA Angiogenesis Revascularization Therapy: Evaluation by RadioNuclide Imaging - The Northern Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00143585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*